ABCC1 and central nervous system cancer: In this study we aimed to investigate the role of SeNPs and 0.2% Cs-SeNPs on the expression levels of genes involved in drug resistance in glioma, including MRP1 (ABCC1) and BRCP (ABCG2), which can predict clinical progression.